Florida Senate - 2018 CS for SB 1788
By the Committee on Children, Families, and Elder Affairs; and
Senator Passidomo
586-02594-18 20181788c1
1 A bill to be entitled
2 An act relating to medication administration training;
3 amending s. 393.506, F.S.; revising competency
4 assessment and validation requirements for direct
5 service providers who administer or supervise the
6 self-administration of medication; providing an
7 effective date.
8
9 Be It Enacted by the Legislature of the State of Florida:
10
11 Section 1. Subsections (2) and (4) of section 393.506,
12 Florida Statutes, are amended, and subsections (1), (3), and (5)
13 of that section are republished, to read:
14 393.506 Administration of medication. —
15 (1) A direct service provider who is not currently licensed
16 to administer medication may supervise the self-administration
17 of medication or may administer oral, transdermal, ophthalmic,
18 otic, rectal, inhaled, enteral, or topical prescription
19 medications to a client as provided in this section.
20 (2) In order to supervise the self-administration of
21 medication or to administer medications as provided in
22 subsection (1), a direct service provider must satisfactorily
23 complete a training course of not less than 8 4 hours in
24 medication administration and be found competent to supervise
25 the self-administration of medication by a client or to
26 administer medication to a client in a safe and sanitary manner.
27 In addition, a direct service provider must annually and
28 satisfactorily complete a 2-hour course in medication
29 administration and error prevention provided by the agency or
30 its designee.
31 (a) Competency must be assessed and validated at least
32 annually if oral or enteral medication administration is
33 performed in the an onsite setting and must include personally
34 observing the direct service provider satisfactorily:
35 1.(a) Supervising the oral or enteral self-administration
36 of medication by a client; and
37 2.(b) Orally or enterally administering medication to a
38 client.
39 (b) Competency must be assessed and validated during the
40 initial medication administration training course if otic,
41 transdermal, or topical medication administration is performed
42 in the onsite setting. The competency assessment must include
43 personally observing the direct service provider satisfactorily
44 simulating otic, transdermal, or topical medication
45 administration.
46 (c) Competency must be assessed and validated and need not
47 be revalidated if ophthalmic, rectal, or inhaled medication
48 administration is performed in the onsite setting. The
49 competency assessment must include the performance of
50 ophthalmic, rectal, or inhaled medication administration on an
51 actual client in the onsite setting.
52 (3) A direct service provider may supervise the self
53 administration of medication by a client or may administer
54 medication to a client only if the client, or the client’s
55 guardian or legal representative, has given his or her informed
56 consent to self-administering medication under the supervision
57 of an unlicensed direct service provider or to receiving
58 medication administered by an unlicensed direct service
59 provider. Such informed consent must be based on a description
60 of the medication routes and procedures that the direct service
61 provider is authorized to supervise or administer. Only a
62 provider who has received appropriate training and has been
63 validated as competent may supervise the self-administration of
64 medication by a client or may administer medication to a client.
65 (4) The determination of competency and annual validation
66 described required in this section shall be conducted by a
67 registered nurse licensed pursuant to chapter 464 or a physician
68 licensed pursuant to chapter 458 or chapter 459.
69 (5) The agency shall establish by rule standards and
70 procedures that a direct service provider must follow when
71 supervising the self-administration of medication by a client
72 and when administering medication to a client. Such rules must,
73 at a minimum, address requirements for labeling medication,
74 documentation and recordkeeping, the storage and disposal of
75 medication, instructions concerning the safe administration of
76 medication or supervision of self-administered medication,
77 informed-consent requirements and records, and the training
78 curriculum and validation procedures.
79 Section 2. This act shall take effect July 1, 2018.